Sign in

CIK 0001386570

  • Large accelerated filer

Niagen Bioscience, Inc.

Sign in to watch
Ticker
NAGE
Exchange
Nasdaq
Industry
Medicinal Chemicals & Botanical Products
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
262940963
Phone
+1 310-388-6706
Business address
10900 WILSHIRE BLVD, SUITE 600, LOS ANGELES, CA, 90024
Former names
ChromaDex Corp., CODY RESOURCES, INC.
  1. 4/A Open-market buy PRESIDENT, COO bought 10,000 shares at $3.63 ($36,300)
  2. 4 Grant or award PRESIDENT, COO acquired 10,000 shares (grant or award)
  3. 4 Open-market sale CEO sold 474 shares at $4.60 ($2,180)
  4. 4 Open-market sale CEO sold 24,578 shares at $4.60 ($113,059)
  5. 4 Derivatives Options or other derivatives
  6. 3 Insider Initial Statement of Ownership
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Open-market sale CEO sold 28,379 shares at an average $6.52 ($184,906)
  11. 4 Open-market sale CEO sold 58,400 shares at $6.19 ($361,496)
  12. 4 Grant or award PRESIDENT, CHIEF STRATEGY OFF. acquired 333,333 shares (grant or award)
  13. 4 Open-market buy 10% owner bought 731,707 shares at $4.10 ($2,999,999)
  14. 4 Derivatives Options or other derivatives
  15. 3 Insider Initial Statement of Ownership
  16. 4 Open-market buy Director bought 2,000 shares at $3.31 ($6,620)
  17. 4 Open-market buy 10% owner bought 1,179,250 shares at $2.60 ($3,066,050)
  18. 4 Open-market buy 10% owner bought 786,167 shares at $2.60 ($2,044,034)
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 9 of 20 · 384 filings